Yarrow Bioscience (YARW) Stock Statistics & Valuation Metrics

Yarrow Bioscience has a market cap or net worth of $28.36M. The enterprise value is $0.63.

Yarrow Bioscience has 859,790 shares outstanding. The number of shares has decreased by -2.65% in one year.

Yarrow Bioscience’s return on equity (ROE) is -0.95 and return on invested capital (ROIC) is -107.15%.

The current PE Ratio of Yarrow Bioscience is ―. Yarrow Bioscience’s PEG ratio is 0.03.

In the last 12 months, Yarrow Bioscience had revenue of 570.00K and earned -26.48M in profits. Earnings per share was -31.00.

In the last 12 months, operating cash flow was -25.74M and capital expenditures 0.00, giving a free cash flow of -25.74M billion.

Yarrow Bioscience pays an annual dividend of $0.402, resulting in a dividend yield of 1.02%

Yarrow Bioscience upcoming earnings date is Aug 19, 2026, Before Open (Confirmed).

Yarrow Bioscience as a current ratio of 12.53, with Debt / Equity ratio of 0.00%

In the past 12 months, Yarrow Bioscience has paid 4.00K in taxes.

Yarrow Bioscience EV to EBITDA ratio is -0.03, with an EV/FCF ratio of -0.02.

Yarrow Bioscience has $24.93M in cash and marketable securities with $0.00 in debt, giving a net cash position of $24.93M billion.

Gross margin is 98.68%, with operating margin of -5219.12%, and net profit margin of -4646.14%.

The average price target for Yarrow Bioscience is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy